• FREE

    Head and Neck Cancer: Current Evidence, Recent Developments, and Future Directions

    Head and Neck Cancer: Current Evidence, Recent Developments, and Future Directions consists of two lectures with discussion, Effective Management Strategies for Head and Neck Cancer and The New Paradigm of Immunotherapy for Head and Neck Cancer, both with Robert I. Haddad, MD and Jared Weiss, MD.

    After viewing Head and Neck Cancer: Current Evidence, Recent Developments, and Future Directions, you will be better able to :
    • Assess the safety and efficacy of available and emerging multimodal regimens, including immunotherapy, for patients with head and neck cancer
    • Utilize strategies to optimally sequence available regimens for the therapeutic management of head and neck cancer
    • Evaluate the latest clinical efficacy and safety data on the use of immune checkpoint inhibitors in head and neck cancer
    • Examine anticipated adverse events related with immune checkpoint inhibitors in head and neck cancer

    Target Audience:
    This program is intended for medical and radiation oncologists, head and neck surgeons, otolaryngologists, ear, nose and throat (ENT) specialists, and other health care professionals (primary care providers, physicians-in-training, oncology nurses, nurse practitioners, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with head and neck cancer.

    • Cost: Free
    • Credit hours: 2
    • CME credits awarded by: Postgraduate Institute for Medicine
    • Format: On-Demand Online, Online Video
    • Material last updated: August 24, 2017
    • Expiration of CME credit: February 24, 2018